Teva Pharmaceutical Industries - 32 Year Dividend History | TEVA
Historical dividend payout and yield for Teva Pharmaceutical Industries (TEVA) since 1992. The current TTM dividend payout for Teva Pharmaceutical Industries (TEVA) as of April 15, 2024 is $0.00. The current dividend yield for Teva Pharmaceutical Industries as of April 15, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$14.911B |
$15.846B |
|
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
